New here? Post 10 threads to unlock access to threads, or upgrade now to access Crax all content instantly!
Join CraxPro and earn real money through our Credit Rewards System. Participate and redeem credits for Bitcoin/USDT. Start earning today!
Read the detailed thread here

kls

Recent contents View information Top users

Description: KLS-13019 is a cannabidiol derivative that has been modified on the side chain to improve solubility and tissue penetration properties. It was developed and patented by Neuropathix subsidiary Kannalife and found to be 50x more potent than cannabidiol as a neuroprotective agent, thought to be mediated by modulation of the sodium-calcium exchanger channel. It also had a higher therapeutic index than cannabidiol. Both KLS-13019 and cannabidiol, prevented the development of CIPN, while only KLS-13019 uniquely reversed neuropathic pain from chemotherapy. KLS-13019 binds to fewer biological targets than cannabidiol and KLS-13019 may possess the unique ability to reverse addictive behaviour, an effect not observed with cannabidiol.

View More On Wikipedia.org